Outsourced Pharma App Notes & Case Studies
-
Secondary Packaging Strategies For Commercial Launch Of A Biologic
8/17/2022
A commercial packaging solution can be the first and enduring impression that a sponsor company makes on a patient, and its suitability can impact a biologic’s commercial success.
-
Implementing High Cell Density Cryopreservation In Your Seed Train
1/22/2023
Simplify seed train intensification with high cell density cryopreservation. Eliminate the need for manual scale-up steps and enable risk reduction through closed banking and inoculation processes.
-
Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma
3/22/2023
Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.
-
Empty/Full Capsid Ratio Of AAV By Sedimentation Velocity – Analytical Ultracentrifugation
9/29/2022
AAV capsids have the potential to impact safety and efficacy. Here we learn more about the results generated from an internal study using AAV8 capsids.
-
Scale Your Process Directly From 3 L To 2,000 L
6/20/2023
Innovative solutions allow you to conceptualize and implement accelerated paths to compress processes while minimizing risk and ensuring product quality.
-
Scalability And Performance Of Mobius® iFlex Bioreactors
1/19/2024
Utilizing single-use bioreactors in intensified fed-batch and perfusion processes can help manufacturers produce a high-quality drug supply while reducing facility footprint and production costs.
-
Lay The Proper Foundation For Upstream Success
4/7/2022
When selecting a partner for development of upstream processes you need speed, quality and regulatory compliance – all appropriately balanced.
-
rAAV Production Using HEK293 Cell Line And Transfection Medium
1/13/2023
Investigate how using a peak expression cell culture medium in the right bioreactor can promote recombinant protein production and improve the performance of a scalable AAV process.
-
Nanomilling From Screening To Scale-Up
1/8/2024
This investigation highlights the strategic use of nanotechnology to overcome formulation challenges and optimize the therapeutic potential of the drug in preparation for clinical trials.
-
Development Of A Novel Cell Culture Medium For AAV Production
9/26/2023
Explore the medium development process of a novel cell culture medium for AAV production with multiple HEK293 lineages, which was performed with three different HEK293 cell lines to maximize AAV titers.